SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Tobira Therapeutics Inc. Announces Positive 24-Week Primary Analysis From Phase 2b Trial of Cenicriviroc in Treatment-Naïve HIV Infection